Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-135-0 | CAS number: 10043-01-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Neurotoxicity
Administrative data
Description of key information
Orale exposure:
The results of the study of Al Moutaery 2000, clearly indicate that the neurological function and recovery rate following SCI are significantly impaired in rats exposed to aluminum sulphate at 250 mg/kg/bw day (LOAEL).
Inhalation exposure:
No brain weight or histological changes were observed in Fischer 344 rats or Hartley guinea pigs exposed by inhalation to up to 38.6 mg /m3 for 6 months (Steinhagen et al. 1978).
Dermal exposure:
No studies were located regarding neurological effects in humans after acute- or intermediate-duration dermal exposure to various forms of
aluminum.
For dermal exposure we taken that:
-the average weight of rats is 250g (200-300g),
-the dose is applied over an area which is approximately 10% of the total body surface=0.025 kg
corrected dermal LOAEL= oral LOAEL
250 mg/kg bw/day 0.025 kg =
LOAELrat 6.3 mg/kg bw/day
Key value for chemical safety assessment
Effect on neurotoxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LOAEL
- 250 mg/kg bw/day
Effect on neurotoxicity: via inhalation route
Endpoint conclusion
- Dose descriptor:
- NOAEC
- 38.6 mg/m³
Effect on neurotoxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LOAEL
- 6.3 mg/kg bw/day
Additional information
Orale exposure:
LABORATORY ANIMALS: Neurotoxicity/.Pregnant mice were injectedintraperitoneally with 200 mg/kg aluminum-sulfate or saline from days 10 to13 of gestation inclusive. A second group of pregnant mice was givenaluminum-sulfate at 750 milligrams/liter as their sole drinking water fromdays ten to 17 of gestation inclusive. Offspring were sacrificed at agesranging from 3 to 44 weeks for determination of choline-acetyltransferaseactivity. For behavioral and developmental studies, pups were crossfostered on postnatal day one. Pups were tested for slow righting, cliffaversion, forelimb grasping, pole grasping, climbing on a wire mesh, andeye opening. At 10 weeks, male mice were tested in an eight arm radialmaze. At 22 weeks, adult activity tested were carried out. The cholinergicsystem, as evaluated by the activity of choline-acetyltransferase, wasaffected differentially in different regions of the brain and still showedsignificant effects in the adult. Differences between the intraperitonealand oral series in the magnitude of effect seen in the regions of thebrain probably reflect differences in the effective level of exposure.
Growth rate and psychomotor maturation in the preweaning mouse wereaffected in the intraperitoneal series only, showing a marked postnatal maternal effect. [Clayton RM et al; Life Sci 51 (25): 1921-1928 (1992
/LABORATORY ANIMALS: Neurotoxicity/:Male, 1 day old white-leghorn-chicks were fed 200 or 400mg/kg aluminum-sulfate (10043013) for 15 days. Cerebral hemispheres were analyzed 24 hours after the last feeding. Cerebral hemisphere tissue homogenates prepared from 1 and 56 day old chicks were incubated with various concentrations of aluminum-sulfate to examine the effects of Al on lipid peroxidation in-vitro. The thiobarbituric-acid (TBA) assay was used to estimate tissue peroxidation. Tissue homogenates from 56 day old animals produced more TBA reactive substances than did homogenates from 1 day old animals. Al dependent peroxidation was only seen using 100 micrograms (microg) of Al in 1 day old chicks and 500microg Al in 56 day old chicks. Peroxidation was evident within 15 minutes of incubation and peaked at 30 minutes. Formation of TBA reactive substances using 1 millimolar Al showed a positive linear relationship with the protein concentration after 30 minutes of incubation. No changes in the body weights, brain weights, heights, endogenous levels of TBA reactive substances, free sulfhydryl levels, or brain protein content were seen in animals which ingested Al for 15 days. [Chainy GBN et al; Bull Environ Contam Toxicol 50 (1): 85-91 (1993)]
/LABORATORY ANIMALS: Neurotoxicity/ Oral administration of Al3+ to rats and chickens fed aluminum sulfate was believed to bind to ferritin and thus secondarily free more cellular Fe2+; such increased activity enhanced membrane lipid peroxidation activity, particularly in the brain. Such phenomena were believed to be related aluminum neurotoxicity. [Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V2 377
/LABORATORY ANIMALS: Neurotoxicity/ We exposed male albino rats for 35 days to aluminum sulfate by gavage. ... Aluminum levels were high in brain specimens of the treated groups comparing to the control and it was dose-dependent. Marked increase in glutamate and glutamine levels was noticed while GABA level was significantly decreased.The most pronounced changes in brain tissue included spongioform changes in the neurons specially those of hippocampus, nuclear deformity, and neurofibrillary degeneration, similar to neurofibrillary tangles in Alzheimer's disease. [El-Rahman SS; Pharmacol Res 47 (3): 189-194 (2003)]
/LABORATORY ANIMALS: Neurotoxicity/ ... Adult male Sprague-Dawley rats classified into different groups were given aluminum sulfate-dosed drinking water in the concentrations of 0%, 0.25%, 0.5% and 1%, respectively. After 30 days of aluminum treatment, the animals were subjected to spinal cord trauma. Laminectomy was performed at T7-8 in anesthetized rats, followed by placement of a compression plate (2.2 x 5 mm) loaded with a 35-g weight over the exposed spinal cord for 5 minutes. Control animals underwent the same surgical procedure, but the compression injury was not induced (sham). Postoperative neurological function was assessed using the inclined-plane test and by obtaining a modified Tarlov score and vocal/sensory score daily for 10 days. Electrophysiological changes were assessed using corticomotor evoked potentials, whereas pathological changes were assessed by light microscopy. The level of vitamin E in the spinal cord was measured as an index of antioxidant defense. The behavioral, biochemical, and histological analyses were performed in a blinded fashion. Analysis of results obtained in the behavioral studies revealed that the compression of spinal cord produced transient paraparesis in which a maximum motor deficit occurred at Day 1 following SCI and resolved over a period of 10 days. Administration of aluminum significantly impaired the recovery following SCI. Analysis of the results of the biochemical, electrophysiological, and histopathological studies also confirmed the deleterious effects of aluminum on recovery from SCI in rats. [Al Moutaery K et al; J Neurosurg 93 (2 Suppl): 276-282 (2000)]
/LABORATORY ANIMALS: Neurotoxicity/ Administration of aluminum sulfate in the drinking water of male Sprague-Dawley rats for thirty days resulted in an impairment of both consolidation and extinction of a passive avoidance task. No impairment of performance was observed on an active avoidance task, radial arm maze or open field activity measure. Biochemical analysis indicated a slight (less than 10%) but significant increase in hippocampal muscarinic receptor number after aluminum treatment as determined by tritiated quinuclidinyl benzilate (3H-QNB) binding. No changes were found in choline acetyltransferase (ChAT) activity, phosphoinositide hydrolysis, 3H-QNB binding in the cortex or tritiated pirenzepine (3H-PZ) binding in the hippocampus or cortex. These results indicate that cholinergic degeneration was not the cause of the observed cognitive impairments. [Connor DJ et al; Pharmacol Biochem Behav 31 (2): 467-474 (1988)]
Dermal exposure:
No studies were located regarding neurological effects in humans after acute- or intermediate-durationdermal exposure to various forms of aluminum.
Graves et al. (1990) examined the association betweenAlzheimer’s disease and the use of aluminum-containing antiperspirants in a case-control study using130 matched pairs. The Alzheimer’s disease was clinically diagnosed at two geriatric psychiatric centers;the controls were friends or nonblood relatives of the Alzheimer patients. Information on lifetime use ofantiperspirants/deodorant was collected via a telephone interview with the subject’s spouse. Noassociation was found between Alzheimer’s disease and antiperspirant/deodorant use, regardless ofaluminum content (odds ratio of 1.2; 95% confidence interval of 0.6–2.4). When only users of aluminumcontainingantiperspirants/deodorants were examined, the adjusted odds ratio was 1.6 (95% confidenceinterval of 1.04–2.4). A trend (p=0.03) toward a higher risk ofAlzheimer’s with increasing use ofaluminum-containing antiperspirants/ deodorants was also found.
Inhalation exposure:
No brain weight or histological changes were observed inFischer 344 rats or Hartley guinea pigs exposed by inhalation to up to 6.1 mg Al/m3 as aluminumchlorhydrate for 6 months (Steinhagen et al. 1978).
Groups of rats and guinea pigs were exposed, by inhalation, to 0.25, 2.5, and 25 mg/m3 of aluminum chlorhydrate (ACH) for six months to study the effects of a common component of antiperspirants. Similar groups of animals of both species exposed to clean air served as controls. The ACH was generated as a particulate dust using a Wright dust feed mechanism. After six months of exposure, animals were sacrificed. Decreases in body weight were seen in rats exposed to 25 mg/m3 of ACH. Marked increases in lung weights and significant increases in lung to body weight ratios were seen in rats and guinea pigs exposed to 25 mg/m3 of ACH. The lungs of all rats and guinea pigs showed significant dose-related increases in aluminum accumulation when exposed to either 0.25, 2.5, or 25 mg/m3 of ACH. The lungs of all rats and guinea pigs exposed to either 2.5 or 25 mg/m3 of ACH contained exposure-related granulomatous reactions characterized by giant vacuoled macrophages containing basophilic material in association with eosinophilic cellular debris.
Justification for classification or non-classification
There are conclusive but not suffcient data for the classification of substance Aluminium sulphate with regard to neurotoxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.